The Journal of Practical Medicine >

2025 , Vol. 41 >Issue 11: 1669 - 1673

DOI: https://doi.org/10.3969/j.issn.1006-5725.2025.11.009

Clinical Research

Characteristics and influencing factors of taste abnormalities in patients with with differentiated thyroid cancer after 131I treatment

  • Pengqing WU ,
  • Kanying LUO ,
  • Qing ZHANG ,
  • Qing ZHANG ,
  • Lingpeng ZENG
Expand
  • *.Department of Nuclear Medicine，the First Affiliated Hospital of Nanchang University，Nanchang 330006，Jiangxi，China

Received date: 2025-02-18

  Online published: 2025-06-19

Fold

Abstract

Objective To explore the characteristics and influencing factors of taste abnormalities in patients with differentiated thyroid cancer （DTC） after 131I treatment. Methods A total of 206 DTC patients who received 131I treatment in the First Affiliated Hospital of Nanchang University from August 2023 to December 2023 were followed up for taste abnormalities， dry mouth， and parotid gland swelling. General clinical data including sex， age， and tumor TNM staging were collected. Based on the presence of taste abnormalities， the patients were divided into abnormal taste group and normal taste group. The differences in general data between the two groups were compared， and multiple logistic regression analysis was used to explore the influencing factors of taste abnormalities. Results Totally， 42.23% of the patients experienced taste abnormalities， including 68 patients with varying degrees of reduced taste， 3 patients with a loss of taste， 6 patients with taste sensitivity， 24 patients with taste hallucinations， and 14 patients with both reduced taste and taste hallucinations. The shortest time for the onset of taste abnormalities was 2 days after 131I treatment， and the longest time was 20 days，with a median time of 7 days； The duration ranged from a minimum of 3 days to a maximum of 60 days， with a median of 14 days. The proportion of dry mouth and parotid gland swelling in patients with abnormal taste was higher than that in those with normal taste， showing statistical significance （P = 0.004， 0.014， respectively）. However， there was no statistical significance in terms of sex age， and tumor TNM stage （P > 0.05）. Multivariate logistic regression analysis showed that dry mouth and parotid gland swelling were risk factors for taste abnormalities in DTC patients treated with 131I （P = 0.007， 0.024， respectively）. Conclusion Abnormal taste is a common adverse reaction in DTC patients after 131I treatment， typically transient， with a median onset time of 7 days post-treatment and a median duration of 14 days. The primary manifestation is reduced taste， with dry mouth and parotid gland swelling identified as risk factors for its occurrence.

Key words： differentiated thyroid cancer; 131I; abnormal taste perception; influence factor

Cite this article

Pengqing WU , Kanying LUO , Qing ZHANG , Qing ZHANG , Lingpeng ZENG . Characteristics and influencing factors of taste abnormalities in patients with with differentiated thyroid cancer after 131I treatment[J]. The Journal of Practical Medicine, 2025 , 41(11) : 1669 -1673 . DOI: 10.3969/j.issn.1006-5725.2025.11.009

References

1 朱枫，李青，陈曦，等. 细针穿刺活检联合高通量测序技术在甲状腺结节诊疗中的应用［J］. 实用医学杂志，2024，40（17）：2471-2476. doi:10.3969/j.issn.1006-5725.2024.17.020
2 HUANG K， HUANG X， QIAN S，et al. Temporal trends of thyroid cancer in China and globally from 1990 to 2021： An analysis of the global burden of Disease Study 2021［J］. Sci Rep， 2024， 14（1）：25538. doi:10.1038/s41598-024-77663-5
3 SCHLUMBERGER M， LEBOULLEUX S. Current practice in patients with differentiated thyroid cancer［J］. Nat Rev Endocrinol， 2021，17（3）：176-188. doi:10.1038/s41574-020-00448-z
4 TABARI A， FARROKH F， BAKHSHI M， et al. Subjective and objective effects of radioiodine therapy on the sense of smell［J］. Eur Arch Otorhinolaryngol， 2024， 281（10）：5319-5324. doi:10.1007/s00405-024-08761-3
5 余荣玲， 陈立， 师凌云， 等. 鼻咽癌患者放化疗后味觉改变和生活质量的交叉滞后研究［J］. 中国卫生统计， 2024，41（1）：135-138.
6 中华医学会核医学分会. 131I治疗分化型甲状腺癌指南（2021版） ［J］. 中华核医学与分子影像杂志，2021，41（4）：218-241. doi:10.3760/cma.j.cn321828-20201113-00412
7 罗依蕤，尼玛吉宗，徐小东，等. 西藏自治区新型冠状病毒感染后嗅觉和味觉障碍的横断面研究［J］. 中国眼耳鼻喉科杂志，2024，24（4）：303-307，313. doi:10.14166/j.issn.1671-2420.2024.04.013
8 ANDROUTSOS L， PALLANTE L， BOMPOTAS A， et al. Predicting multiple taste sensations with a multiobjective machine learning method［J］. NPJ Sci Food， 2024，8（1）：47. doi:10.1038/s41538-024-00287-6
9 AFRAMIAN D J， ZEDAN A， AGBARIAH W， et al. Quantitive Assessment of Gustatory Function and Its Association with Demographics， and Systemic Morbidity［J］. Biology （Basel）， 2024， 13（1）：50. doi:10.3390/biology13010050
10 JAFARI A.， ALAEE AND K A.. GHODS， The etiologies and considerations of dysgeusia： A review of literature［J］. J Oral Biosci， 2021， 63（4）： p. 319-326. doi:10.1016/j.job.2021.08.006
11 李莹，李清，王璇，等. 原发性灼口综合征的研究进展［J］. 实用医学杂志，2022，38（19）：2486-2490.
12 贾英男， 李娜. 术后DTC患者~（131）I治疗后不良反应的研究进展［J］. 当代医学， 2019，25（13）：191-194. doi:10.3969/j.issn.1009-4393.2019.13.080
13 陈嘉荣，阮扬皓，张银英，等. 阿片类药物治疗鼻咽癌患者放射性口腔黏膜炎疼痛的研究进展［J］. 新医学，2020，51（8）：576-580. doi:10.3969/j.issn.0253-9802.2020.08.002
14 OKADA N， HANAFUSA T， ABE S， et al. Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation： possible usefulness of cryotherapy in dysgeusia prevention［J］. Support Care Cancer， 2016，24（9）：3979-3985. doi:10.1007/s00520-016-3244-9
15 DESHPANDE T S， BLANCHARD P， WANG L， et al. Radiation-Related Alterations of Taste Function in Patients With Head and Neck Cancer： a Systematic Review［J］. Curr Treat Options Oncol， 2018，19（12）：72. doi:10.1007/s11864-018-0580-7
16 中山大学附属第三医院甲状腺多学科诊疗中心. 甲状腺乳头状癌（初诊）一体化诊疗路径——中山大学附属第三医院甲状腺多学科诊疗中心专家共识［J］. 新医学，2025，56（2）：109-123. doi:10.12464/j.issn.0253-9802.2024-0363
17 ALEXANDER C， BADER J B， SCHAEFER A， et al. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma［J］. J Nucl Med， 1998，39（9）：1551-1554.
18 GREWAL R K， LARSON S M， PENTLOW C E， et al. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation［J］. J Nucl Med， 2009，50（10）：1605-1610. doi:10.2967/jnumed.108.061382
19 TUTAR B， ?ZüLKER T， BERKITEN G，et al. Does the radioactive iodine dose affect smell， taste sensation and nose function［J］. J Laryngol Otol， 2021， 135（1）：50-56. doi:10.1017/s0022215120002571
20 STIEB S， ENGESETH GM， MOHAMED ASR， et al. The influence of radiation dose on taste impairment in a prospective observational study cohort of oropharyngeal cancer patients［J］. Acta Oncol， 2022， 61（2）：146-152. doi:10.1080/0284186x.2021.2022204
21 倪玉丹， 陈玉红， 徐莉， 等. 老年消化道肿瘤病人化疗相关性味觉改变及对营养、心理状态和生活质量的影响［J］. 实用老年医学， 2021，35（5）：451-454. doi:10.3969/j.issn.1003-9198.2021.05.005
22 HORVATH E， SKOKNIC V， MAJLIS S， et al. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer： Radioactive Iodine Activity and Risk［J］. Thyroid， 2020，30（11）：1646-1655. doi:10.1089/thy.2019.0563
23 RAVERA S， NICOLA J P， SALAZAR-DE S G， et al. Structural insights into the mechanism of the sodium/iodide symporter［J］. Nature， 2022，612（7941）：795-801. doi:10.1038/s41586-022-05530-2
24 BADAM R K， SURAM J， BABU D B， et al. Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients［J］. J Clin Diagn Res， 2016，10（1）：C60-C62.
25 ROSATI D， MASTINO P， ROMEO M， et al. Taste and Smell Alterations （TSAs） in Cancer Patients［J］. Diseases， 2024， 12（6）：130. doi:10.3390/diseases12060130
26 MORTAZAVI SMJ， NOWROOZI S， HAGHANI M， et al. Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment［J］. Cancers （Basel）， 2023， 15（3）：740. doi:10.3390/cancers15030740
Options
Outlines

/

〈 〉